Highlights and Quick Summary
- Shareholders Equity (Tangible) for the quarter ending September 30, 2023 was $1.7 Million (a -108.58% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity (Tangible) decreased by -84.04%
- Annual Shareholders Equity (Tangible) for 2022 was $10.7 Million (a -74.76% decrease from previous year)
- Annual Shareholders Equity (Tangible) for 2021 was $42.2 Million (a -12.14% decrease from previous year)
- Annual Shareholders Equity (Tangible) for 2020 was $48.1 Million (a -30.4% decrease from previous year)
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Tangible) of ARAVIVE, INC
Most recent Shareholders Equity (Tangible)of ARAV including historical data for past 10 years.Interactive Chart of Shareholders Equity (Tangible) of ARAVIVE, INC
ARAVIVE, INC Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $1.7 | $-19.82 | $-38.61 | – | – |
| 2022 | $10.66 | $15.04 | $30.07 | $39.2 | $10.66 |
| 2021 | $42.22 | $54.34 | $64.06 | $68.72 | $42.22 |
| 2020 | $48.06 | $49.37 | $59.45 | $59.0 | $48.06 |
| 2019 | $69.05 | $47.53 | $52.87 | $54.96 | $69.05 |
| 2018 | $59.95 | $63.72 | $68.94 | $76.63 | $59.95 |
| 2017 | $82.76 | $49.24 | $95.02 | $126.5 | $82.76 |
| 2016 | $151.07 | $111.0 | $135.74 | $154.7 | $151.07 |
| 2015 | $176.5 | $194.18 | $212.25 | $227.58 | $176.5 |
| 2014 | $167.37 | $181.23 | $193.47 | $201.1 | $167.37 |
| 2013 | – | – | – | $10.21 | $10.21 |
| 2012 | $-5.1 | – | – | – | $-5.1 |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology